A small group of academics and government scientists work without financial gain to develop a gene editing technique to halt progeria, potentially aiding other rare genetic diseases with no treatments.
After decades of research, they are planning a clinical trial for progeria gene editing, with risks highlighted by Dr. Kiran Musunuru, emphasizing the uncertainty of success in human patients.
[
Collection
]
[
|
...
]